How many shares of BMRN does DODGE & COX own?

As of 2026-Q2, DODGE & COX holds 14.8M shares of BMRN (BIOMARIN PHARMACEUTICAL INC).

What is DODGE & COX's BMRN position worth?

As of 2026-Q2, DODGE & COX's BMRN position is worth $849.4M.

In 2026-Q2, DODGE & COX increased their BMRN position (+1.9% change in shares).

Based on available 13F filings, DODGE & COX first reported a position in BMRN in 2019-Q4. They have held the position across 27 quarters.

Position history for DODGE & COX's holdings in BIOMARIN PHARMACEUTICAL INC

Current Value

$849.4M

Current Shares

14.8M

Total Value Change

+$478.3M

Total Shares Change

+10.5M

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	14.8M	+1.9%	$849.4M	0.4%	$57.22	39
2026-Q1	Decreased	14.6M	-0.1%	$822.6M	0.5%	$56.49	0
2025-Q4	Decreased	14.6M	-0.8%	$866M	0.5%	$59.43	0
2025-Q3	Decreased	14.7M	-2.8%	$795.4M	0.4%	$54.16	0
2025-Q2	Increased	15.1M	+1.0%	$830.5M	0.5%	$54.97	38
2025-Q1	Increased	15M	+1.4%	$1.1B	0.6%	$70.69	46
2024-Q4	Increased	14.7M	+6.1%	$969.3M	0.6%	$65.73	48
2024-Q3	Decreased	13.9M	-0.2%	$976.9M	0.6%	$70.29	0
2024-Q2	Decreased	13.9M	-0.5%	$1.1B	0.7%	$82.33	0
2024-Q1	Decreased	14M	-0.0%	$1.2B	0.7%	$87.34	0
2023-Q4	Decreased	14M	-1.1%	$1.3B	0.9%	$96.42	0
2023-Q3	Decreased	14.2M	-1.0%	$1.3B	0.8%	$88.48	0
2023-Q2	Decreased	14.3M	-0.3%	$1.2B	0.8%	$86.68	0
2023-Q1	Decreased	14.3M	-0.4%	$1.4B	0.9%	$97.24	0
2022-Q4	Decreased	14.4M	-2.6%	$1.5B	1.0%	$103.49	0
2022-Q3	Decreased	14.8M	-1.6%	$1.3B	0.9%	$84.77	0
2022-Q2	Decreased	15M	-0.2%	$1.2B	0.9%	$82.87	0
2022-Q1	Increased	15M	+1.4%	$1.2B	0.7%	$77.10	46
2021-Q4	Increased	14.8M	+0.0%	$1.3B	0.8%	$88.35	45
2021-Q3	Increased	14.8M	+5.1%	$1.1B	0.7%	$77.29	47
2021-Q2	Increased	14.1M	+19.0%	$1.2B	0.8%	$83.44	53
2021-Q1	Increased	11.9M	+21.0%	$895.1M	0.6%	$75.51	54
2020-Q4	Increased	9.8M	+26.9%	$859.1M	0.7%	$87.69	56
2020-Q3	Increased	7.7M	+113.5%	$587.4M	0.5%	$76.08	72
2020-Q2	Decreased	3.6M	-8.3%	$446M	0.4%	$123.34	0
2020-Q1	Decreased	3.9M	-10.2%	$333.1M	0.4%	$84.50	0
2019-Q4	New	4.4M	-	$371.1M	0.3%	$84.55	51